• 03: Plasma Microbial Cell-Free DNA NGS In Immunocompromised Pneumonia

  • Dec 12 2024
  • Durée: 14 min
  • Podcast

03: Plasma Microbial Cell-Free DNA NGS In Immunocompromised Pneumonia

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • This multicenter study investigated the clinical utility of plasma microbial cell-free DNA (mcfDNA) sequencing as an adjunctive diagnostic tool for pneumonia in immunocompromised patients. Researchers compared the diagnostic yield of mcfDNA sequencing to standard clinical testing in a prospective observational trial. The results demonstrated that mcfDNA sequencing significantly increased the detection of pneumonia etiologies, particularly in cases where conventional methods failed. This non-invasive approach offers a potential improvement in the diagnosis and treatment of pneumonia in this vulnerable population. The study also noted some limitations, including incomplete standard testing in a subset of patients and the impact of prior antimicrobial therapy.


    Created with NotebookLM by Google so there may be mistakes and/or errors.


    PMID: 37815489

    Bergin SP, Chemaly RF, Dadwal SS, et al. Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational Study. Clin Infect Dis 2024;78(3):775–84.
    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de 03: Plasma Microbial Cell-Free DNA NGS In Immunocompromised Pneumonia

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.